Vilanterol

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Vilanterol and local guidelines before prescribing.

Long-acting beta-2 agonist

Mechanism

Ultra-long-acting beta-2 agonist (in combination inhalers).

Uses

Asthma and COPD (with inhaled steroid or antimuscarinic).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Tremor, palpitations, headache, cough.

Interactions

Beta-blockers; ketoconazole.

Contraindications and cautions

Not for acute relief

Monitoring

Asthma control

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Once-daily combination inhalers.

More from the textbook: uses, cautions and other points
Where it is discussed in the book